Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59352-5 Tapentadol MCnc Bld Pt Qn     ACTIVE Tapentadol [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 0.5 ng/mL           DRUG/TOX   59352-5         Both       0 Tapentadol Bld-mCnc       N   Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal; WB; Whole blood 2.73 2.32               ng/mL       0
59353-3 Tapentadol MCnc Body fld Pt Qn     ACTIVE Tapentadol [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 0.5 ng/mL           DRUG/TOX   59353-3         Both       0 Tapentadol Fld-mCnc       N   Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal 2.7 2.32               ng/mL       0
59354-1 Tapentadol MCnc Ser/Plas Pt Qn     ACTIVE Tapentadol [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ng/mL 0.5 ng/mL           DRUG/TOX   59354-1         Both       0 Tapentadol SerPl-mCnc       N   Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Nucynta; Palexia; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tapal 2.73 2.32               ng/mL       0
59355-8 Tapentadol MCnt Tiss Pt Qn     ACTIVE Tapentadol [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 0.5 ng/g           DRUG/TOX   59355-8         Both       0 Tapentadol Tiss-mCnt       N   Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal; Tissue; Tissue, unspecified 2.7 2.32               ng/g     Changed Property from 'MCnc' it fit the current LOINC model. 0
59356-6 Desethylvardenafil MCnc Bld Pt Qn     ACTIVE Desethylvardenafil [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59356-6         Both       0 Desethylvardenafil Bld-mCnc       N   Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; Vardenafil metabolite; WB; Whole blood 2.7 2.32               ng/mL       0
59357-4 Vardenafil MCnc Bld Pt Qn     ACTIVE Vardenafil [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59357-4         Both       0 Vardenafil Bld-mCnc       N   Blood; DRUG/TOXICOLOGY; Drugs; Level; Levitra; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.7 2.32               ng/mL       0
59358-2 Desethylvardenafil MCnc Ser/Plas Pt Qn     ACTIVE Desethylvardenafil [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59358-2         Both       0 Desethylvardenafil SerPl-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vardenafil metabolite 2.7 2.32               ng/mL       0
59359-0 Vardenafil MCnc Ser/Plas Pt Qn     ACTIVE Vardenafil [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59359-0         Both       0 Vardenafil SerPl-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Levitra; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.7 2.32               ng/mL       0
5936-0 Benzoylecgonine MCnt Hair Pt Qn     ACTIVE Benzoylecgonine [Mass/mass] in Hair   MIN DefinitionDescription     ng/g             DRUG/TOX   5936-0         Both       0 BZE Hair-mCnt       Y   BEC; BEG; Benz; Benzoylec; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random 2.73 1.0d               ng/g       0
59360-8 Desethylvardenafil MCnc Urine Pt Qn     ACTIVE Desethylvardenafil [Mass/volume] in Urine   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59360-8         Both       0 Desethylvardenafil Ur-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vardenafil metabolite 2.7 2.32               ng/mL       0
59361-6 Vardenafil MCnc Urine Pt Qn     ACTIVE Vardenafil [Mass/volume] in Urine   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59361-6         Both       0 Vardenafil Ur-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Levitra; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.7 2.32               ng/mL       0
59362-4 Race or ethnicity Type ^Patient Pt Nom OMB.1997   ACTIVE Race or ethnicity OMB.1997   MIN DefinitionDescription             PID-10;PID-22     CLIN   59362-4   OMB.1997     Both       0 Race or ethnicity OMB.1997       N   CLIN; Ethnicity; Nominal; Point in time; Random; Typ 2.63 2.32                     Changed method from 'MDSv3' to 'OMB.1997' since the MDSv3 answer list is the same as OMB's combined race & ethnicity answer list (1997). OMB provides standards that promote uniformity and comparability for data on race and ethnicity throughout the U.S. Federal Government. These standards are widely adopted, including in the EHR Meaningful Use program within the U.S. 0
59363-2 Leptospira interrogans serovar Manhao Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Manhao Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59363-2   Aggl     Both       0 L inter Manhao Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Manhao; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59364-0 Leptospira interrogans serovar Pyrogenes Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Pyrogenes Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59364-0   Aggl     Both       0 L inter Pyrogenes Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Pyrogenes; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59365-7 Leptospira interrogans serovar Mini Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Mini Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59365-7   Aggl     Both       0 L inter Mini Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Mini; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59366-5 Leptospira interrogans serovar Sejroe Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Sejroe Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59366-5   Aggl     Both       0 L inter Sejroe Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Sejroe; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59367-3 Leptospira interrogans serovar Tarassovi Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Tarassovi Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59367-3   Aggl     Both       0 L inter Tarassovi Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Tarassovi; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59368-1 Leptospira interrogans serovar Bataviae Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Bataviae Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59368-1   Aggl     Both       0 L inter Batav Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Batav; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59369-9 Leptospira interrogans serovar Hebdomadis Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Hebdomadis Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59369-9   Aggl     Both       0 L inter Hebdo Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Hebdo; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
5937-8 Cocaine MCnc Urine Pt Qn     DEPRECATED Deprecated Cocaine [Mass/volume] in Urine   DEL DefinitionDescription     ng/mL             DRUG/TOX   5937-8                 0 Deprecated Cocaine Ur-mCnc           Addiction; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Snow; UA; UR; Urn 2.4 1.0d       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59370-7 Leptospira interrogans serovar Australis Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Australis Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59370-7   Aggl     Both       0 L inter Austral Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Austral; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59371-5 Leptospira interrogans serovar Autumnalis Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Autumnalis Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59371-5   Aggl     Both       0 L inter Autum Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Autum; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59372-3 Leptospira interrogans serovar Ballum Ab Titr Ser Pt SemiQn Aggl   ACTIVE Leptospira interrogans sv Ballum Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   59372-3   Aggl     Both       0 L inter Ballum Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Ballum; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.32               {titer}       0
59373-1 Special treatments &or programs - none of above - while a resident Find ^Patient Pt Ord MDSv3   ACTIVE Special treatments andor programs - none of above - while a resident [MDSv3]   MIN DefinitionDescription                   SURVEY.MDS   59373-1   MDSv3             0         N   Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Special Txs/programs - none of above; Survey; SURVEY.MDS; Tx; Txs 2.44 2.32                       0
59374-9 Special treatments &or programs - none of above - while NOT a resident Find ^Patient Pt Ord MDSv3   ACTIVE Special treatments andor programs - none of above - while NOT a resident [MDSv3]   MIN DefinitionDescription                   SURVEY.MDS   59374-9   MDSv3             0         N   Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Special Txs/programs - none of above; Survey; SURVEY.MDS; Tx; Txs 2.44 2.32                       0
104,672 results found